Health
Johnson & Johnson’s COVID-19 vaccine shows promising response in early trial after one dose – WSYM-TV
Results from early stage trials of Johnson & Johnsons COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.
The company plans to release more details in a few weeks, and apply for emergency use authorization from the FDA in February.
Researchers say
Phase 1-2 of the vaccine showed either one or two doses of the vaccine generated both antibody and T-cell responses against the coronavirus. The vaccines efficacy,…
-
Noosa News23 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business21 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
General23 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers